Possible Lurasidone-Associated Dose-Dependent QTc Prolongation in First-Episode Psychosis.

Authors :: Naguy A
Al-Khadhari S
Pridmore S
Source :: Psychopharmacology bulletin [Psychopharmacol Bull] 2022 Jun 27; Vol. 52 (3), pp. 68-71.
Publication Year :: 2022
Abstract: This case is one of the earliest to report on lurasidone-related QTc prolongation in a dose-dependent fashion in CAP population at therapeutic doses. Although these reports remain scarce, it behoves prescribers to be vigilant and mindful of these unusual but serious side effects especially in setting of cumulative risks.<br /> (Copyright © 1964–2022 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States.)

Subjects :: Electrocardiography
Humans
Lurasidone Hydrochloride adverse effects
Antipsychotic Agents adverse effects
Drug-Related Side Effects and Adverse Reactions
Long QT Syndrome chemically induced
Long QT Syndrome drug therapy
Psychotic Disorders drug therapy

Tools